8049.HK

Jilin Province Huinan Changlong Bio-pharmacy Company Limited 8049.HK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 8049.HK 0950.HK 1349.HK 2500.HK 0239.HK 2407.HK 6639.HK 2251.HK 2257.HK 2348.HK
6M 36.25 % 54.69 % 40.60 % 11.98 % 6.22 % 71.51 % 3.74 % 20.73 % 330.74 % 5.31 %
YTD 57.97 % 37.50 % 39.41 % 11.98 % -3.63 % -3.81 % -28.94 % 9.93 % 265.33 % -1.65 %
1Y 51.39 % 59.68 % 11.90 % 11.98 % -2.05 % 1.34 % -41.57 % 17.73 % 307.35 % -3.25 %
3Y 144.94 % 42.45 % 16.67 % -72.18 % 121.30 % -82.32 % -72.98 % 31.49 % -79.89 % 14.42 %
5Y 57.97 % -61.92 % -13.42 % -96.45 % 32.04 % -82.32 % -85.94 % -80.47 % -83.63 % 32.22 %
10Y -24.83 % -81.67 % -57.98 % -93.70 % -37.92 % -82.32 % -85.94 % -80.47 % -83.63 % -63.94 %
From the beginning 59.12 % 280.77 % 311.25 % -93.70 % 312.66 % -82.32 % -85.94 % -80.47 % -83.63 % 186.75 %

Dividend

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Lee's Pharmaceutical Holdings Limited

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Pak Fah Yeow International Limited

Gaush Meditech Ltd

Dawnrays Pharmaceutical (Holdings) Limited